| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9628 |
| Human Intestinal Absorption | HIA+ | 0.8769 |
| Caco-2 Permeability | Caco2+ | 0.6854 |
| P-glycoprotein Substrate | Non-substrate | 0.7271 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8423 |
| Non-inhibitor | 0.8042 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8321 |
| Distribution |
| Subcellular localization | Mitochondria | 0.9540 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7779 |
| CYP450 2D6 Substrate | Non-substrate | 0.9386 |
| CYP450 3A4 Substrate | Non-substrate | 0.7649 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6262 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7253 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9191 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7547 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9330 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7188 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9747 |
| Non-inhibitor | 0.9503 |
| AMES Toxicity | Non AMES toxic | 0.9728 |
| Carcinogens | Non-carcinogens | 0.7404 |
| Fish Toxicity | High FHMT | 0.9681 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9904 |
| Honey Bee Toxicity | High HBT | 0.5690 |
| Biodegradation | Ready biodegradable | 0.7260 |
| Acute Oral Toxicity | III | 0.7062 |
| Carcinogenicity (Three-class) | Non-required | 0.7579 |